Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ginger supplement tested as natural Anti-Inflammatory for heart health

NCT ID NCT07437222

Disease control Sponsor: Ana Mª Garcia Munoz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether taking ginger capsules daily for 60 days can lower inflammation and oxidative stress in adults with excess body fat. Fifty participants will be randomly assigned to receive either ginger or a placebo. The goal is to see if ginger can improve markers linked to heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ginger capsules
What this could lead to
If it works, this could point toward a simple, natural supplement to help control inflammation and reduce heart disease risk in people with excess weight.
What could go wrong
This is a small, early-stage trial with only 50 participants. The results may not apply to everyone, and ginger may not show a significant effect compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

23 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and female participants. * Age between 23 and 65 years. * Body mass index (BMI) \> 27.5 kg/m². * Absence of diagnosed chronic diseases. * Not receiving pharmacological treatment or dietary supplementation on a regular basis. * Ability to understand the study procedures and willingness to comply with study requirements. Exclusion Criteria: * Presence of acute or chronic diseases not specified in the inclusion criteria. * Ongoing chronic pharmacological treatment or active use of dietary supplements. * Major surgery within the previous three months. * Current smokers or recent former smokers (less than six months since cessation). * History of clinically relevant food allergies or eating disorders. * Concurrent participation in another clinical trial or research study. * Pregnancy or breastfeeding. * Following an active weight-loss diet. * Investigator's judgment of unsuitability for study participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiometabolic risk factors are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiometabolic risk factors Inflammation biomarkers Oxidative stress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universidad Católica San Antonio de Murcia

    RECRUITING

    Murcia, Murcia, 30107, Spain

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.